Cassidy Henegar is an experienced pharmacoepidemiologist with expertise in the design and conduct of non-interventional studies, primarily in the infectious disease therapeutic area. She is passionate about conducting research that contributes to the development of better treatment options for HIV and that appropriately addresses the unique needs of people living with HIV. In her current role, she is responsible for developing and executing real-world evidence strategies to address safety and effectiveness data needs for HIV-specific products across the ViiV portfolio. She is working in a highly matrixed environment and is effective at partnering with colleagues across R&D, Safety, Medical Affairs, and Commercial teams to identify evidence needs and design and deliver appropriate studies.
Cassidy Henegar is an experienced pharmacoepidemiologist with expertise in the design and conduct of non-interventional studies, primarily in the infectious disease therapeutic area. She is passionate about conducting research that contributes to the development of better treatment options for HIV and that appropriately addresses the unique needs of people living with HIV. In her current role, she is responsible for developing and executing real-world evidence strategies to address safety and effectiveness data needs for HIV-specific products across the ViiV portfolio. She is working in a highly matrixed environment and is effective at partnering with colleagues across R&D, Safety, Medical Affairs, and Commercial teams to identify evidence needs and design and deliver appropriate studies.